Main Session
Sep
30
SS 37 - Head and Neck 4: Refining Radiation: What Clinical Trials Can Tell Us
315 - Marrow-Derived Autologous Stromal Cells for the Restoration of Salivary Hypofunction (MARSH): A Phase 1 Dose-Escalation Trial of Patients with Xerostomia after Radiation Therapy for Head and Neck Cancer
Presenter(s)
Grace Blitzer, MD - University of Wisconsin Madison, Madison, WI